adjunctive mao-b or comt inhibitors to optimize levodopa treatment in pd
Published 1 year ago • 275 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:18
adjunctive mao-b or comt inhibitors for parkinson's disease
-
42:34
parkinson's medications - part 2: dopamine agonists, mao-b inhibitors, and more
-
30:22
repositioning comt inhibitors and response duration in levodopa optimisation – round table
-
2:35
levodopa dose adjustment versus adjunctive therapy in parkinson’s disease
-
17:53
parkinson's disease drugs iii: dopamine agonists & comt/mao-b inhibitors
-
2:29
comt inhibitors for parkinson's disease
-
41:11
parkinson's disease medications overview - uf pd symposium 2022
-
15:18
comt inhibitors || in parkinson disease
-
35:02
moving toward optimal management of advanced parkinson’s disease
-
4:28
opicapone: an adjuvant to levodopa in pd therapy
-
1:19
maob inhibitors for the treatment of parkinson’s
-
1:18
comt inhibitors for motor fluctuations in parkinson’s disease
-
4:37
parkinson’s pharmacology - neurology
-
35:35
new diagnosis workshop series (2023): pd management and treatment
-
1:00:19
maximizing parkinson's disease medications: how to get the most out of your treatment plan
-
1:00:12
a dive into the different parkinson's drug classes
-
30:29
a2a receptor antagonists: potential adjuvant therapies for levodopa optimisation
-
1:06
comt inhibitors for parkinson’s disease: clinical updates
-
1:52
mao inhibitors for parkinson's disease